cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Stockal+Disclaimer.pdf
35 own
30 watching
Current Price
$6.66
$-0.16
(-2.35%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
623.67M
52-Week High
52-Week High
18.95800
52-Week Low
52-Week Low
5.77000
Average Volume
Average Volume
0.89M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization623.67M
icon52-Week High18.95800
icon52-Week Low5.77000
iconAverage Volume0.89M
iconDividend Yield--
iconP/E Ratio--
What does the Stockal+Disclaimer.pdf do?
Developing a proprietary hydrogen peroxide treatment for common skin lesions.
Read More
How much money does Stockal+Disclaimer.pdf make?
News & Events about Stockal+Disclaimer.pdf.
Stock Options Channel
3 months ago
Investors eyeing a purchase of Aclaris Therapeutics Inc (ACRS) shares, but tentative about paying the going market price of 9.86/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the February ...
Ticker Report
6 months ago
Aclaris Therapeutics, Inc. (NASDAQ:ACRS Get Rating) Stock analysts at Jefferies Financial Group boosted their FY2025 earnings per share estimates for Aclaris Therapeutics in a note issued to investors on Monday, March 6th. Jefferies Financial Group analyst R. Song now expects that ...
Zolmax
6 months ago
Aclaris Therapeutics (NASDAQ:ACRS Get Rating) had its target price decreased by The Goldman Sachs Group from $25.00 to $21.00 in a report released on Tuesday , Benzinga reports. The Goldman Sachs Group currently has a buy rating on the biotechnology companys stock. Several other research analysts ...
Benzinga
6 months ago
Gainers Unicycive Therapeutics, Inc. (NASDAQ: UNCY) shares surged 159% to $1.27 after the company announced a private placement of up to $130 million in gross proceeds to commercialize and launch Renazorb. read more...
Globe Newswire
8 months ago
WAYNE, Pa., Jan. 06, 2023 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today is providing a corporate outlook for 2023. 2023 is setting up to be an incredibly ...
Frequently Asked Questions
Frequently Asked Questions
What is Stockal+Disclaimer.pdf share price today?
plus_minus_icon
Can Indians buy Stockal+Disclaimer.pdf shares?
plus_minus_icon
How can I buy Stockal+Disclaimer.pdf shares from India?
plus_minus_icon
Can Fractional shares of Stockal+Disclaimer.pdf be purchased?
plus_minus_icon
What are the documents required to start investing in Stockal+Disclaimer.pdf stocks?
plus_minus_icon
What is today’s traded volume of Stockal+Disclaimer.pdf?
plus_minus_icon
What is today’s market capitalisation of Stockal+Disclaimer.pdf?
plus_minus_icon
What is the 52-Week High and Low Range of Stockal+Disclaimer.pdf?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf down from its 52-Week High?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf up from its 52-Week Low?
plus_minus_icon
Current Price
$6.66
$-0.16
(-2.35%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Voyager Therapeutics, Inc.
Voyager Therapeutics, Inc.
$7.59
$-0.14 (-1.81 %)
Arbutus Biopharma Corporation
Arbutus Biopharma Corporation
$1.93
$-0.06 (-3.02 %)
Ardelyx Inc
Ardelyx Inc
$3.95
$0.29 (7.92 %)
MARINUS PHARMACEUTICALS INC
MARINUS PHARMACEUTICALS INC
$6.60
$-0.15 (-2.22 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Voyager Therapeutics, Inc.
Voyager Therapeutics, Inc.
$7.59
$-0.14 (-1.81 %)
Arbutus Biopharma Corporation
Arbutus Biopharma Corporation
$1.93
$-0.06 (-3.02 %)
Ardelyx Inc
Ardelyx Inc
$3.95
$0.29 (7.92 %)
MARINUS PHARMACEUTICALS INC
MARINUS PHARMACEUTICALS INC
$6.60
$-0.15 (-2.22 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00